Skip to main content
Top
Published in: BMC Ophthalmology 1/2017

Open Access 01-12-2017 | Research article

Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye

Authors: Peter J. McDonnell, Stephen C. Pflugfelder, Michael E. Stern, David R. Hardten, Taryn Conway, Linda Villanueva, David A. Hollander

Published in: BMC Ophthalmology | Issue 1/2017

Login to get access

Abstract

Background

The aim of this research is to initiate a 5-year natural history study of dry eye disease (DED) using objectively assessed and patient-reported outcomes, to explore the hypothesis that DED is a progressive condition that has substantive and measurable impacts not only on the ocular surface, but on quality of life and visual functioning. Our objective for this report is to examine the baseline data.

Methods

A multicenter, prospective, controlled, observational study of Level 2 (mild-to-moderate) DED patients based on International Task Force Delphi Panel severity grading, and controls, documented baseline measures (including tear film biomarkers and quality of life). Tear cytokine concentrations were also measured in the tear film. Patients were using artificial tears as needed.

Results

Two hundred seventeen DED patients and 67 gender- and age-matched controls were enrolled. A majority were females and Caucasian and groups did not differ significantly in terms of gender, race, or age. Differences between DED and matched controls, at baseline, included mean scores for Ocular Surface Disease Index (31.7 vs 4.1, P < 0.0001), Schirmer test (5.7 vs 15.3 mm, P < 0.0001), corneal staining (1.4 vs 0.2, P < 0.0001), conjunctival staining (1.4 vs 0.3, P < 0.0001), and tear break-up time (5.7 vs 8.5 s, P < 0.0001). Tear cytokines levels were determined and included interferon-γ, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, tumor necrosis factor-α, epidermal growth factor, IL-13, IL-17, IL-1α, and inducible protein-10. The mean levels of IL-8 and IL-6 were slightly higher in the DED group at baseline. Blurred vision was reported as moderate/severe/very severe at baseline in 57.6% of DED patients vs.10.5% of normal controls (P < 0.0001). DED patients reported greater reductions in work and non-work productivity, as well as greater need for visits to ophthalmologists during the prior year.

Conclusions

In this report of the baseline findings of a 5-year natural history study of DED, a striking disease burden is observed with regard to blurred vision, productivity, and visits to eye care practitioners in mild to moderate DED patients compared to normal subjects of similar ages and genders.

Trial registration

ClinicalTrials.​gov NCT00833235 on January 30, 2009.
Literature
1.
2.
go back to reference Lienert JP, Tarko L, Uchino M, Christen WG, Schaumberg DA. Long-term natural history of dry eye disease from the patient's perspective. Ophthalmology. 2016;123:425–33.CrossRefPubMed Lienert JP, Tarko L, Uchino M, Christen WG, Schaumberg DA. Long-term natural history of dry eye disease from the patient's perspective. Ophthalmology. 2016;123:425–33.CrossRefPubMed
3.
go back to reference Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians’ Health Studies. Arch Ophthalmol. 2009;127:763–8. Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians’ Health Studies. Arch Ophthalmol. 2009;127:763–8.
4.
go back to reference Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318–26.CrossRefPubMed Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318–26.CrossRefPubMed
5.
go back to reference McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne. Australia Ophthalmology. 1998;105:1114–9.CrossRefPubMed McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne. Australia Ophthalmology. 1998;105:1114–9.CrossRefPubMed
6.
go back to reference Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai eye study. Ophthalmology. 2003;110:1096–101.CrossRefPubMed Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai eye study. Ophthalmology. 2003;110:1096–101.CrossRefPubMed
7.
go back to reference The epidemiology of dry eye disease. Report of the epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:93–107. The epidemiology of dry eye disease. Report of the epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:93–107.
9.
go back to reference Barabino S, Chen Y, Chauhan S, Dana R. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res. 2012;31:271–85.CrossRefPubMedPubMedCentral Barabino S, Chen Y, Chauhan S, Dana R. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res. 2012;31:271–85.CrossRefPubMedPubMedCentral
12.
go back to reference Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, Hamann S, Larkin G, McNamara NA, Greenspan JS, Daniels TE. Sjögren’s international collaborative clinical alliance research groups. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s syndrome International Registry. Am J Ophthalmol. 2010;149:405–15. Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, Hamann S, Larkin G, McNamara NA, Greenspan JS, Daniels TE. Sjögren’s international collaborative clinical alliance research groups. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s syndrome International Registry. Am J Ophthalmol. 2010;149:405–15.
13.
go back to reference Stonecipher KG, Chia J, Onyenwenyi A, Villanueva L, Hollander DA. Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients. Ther Clin Risk Manag. 2013;9:409–15.CrossRefPubMedPubMedCentral Stonecipher KG, Chia J, Onyenwenyi A, Villanueva L, Hollander DA. Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients. Ther Clin Risk Manag. 2013;9:409–15.CrossRefPubMedPubMedCentral
14.
go back to reference Behrens A, Doyle JJ, Stern L, Chuck RS, McDonnell PJ, Azar DT, Dua HS, Hom M, Karpecki PM, Laibson PR, Lemp MA, Meisler DM, Del Castillo JM, O'Brien TP, Pflugfelder SC, Rolando M, Schein OD, Seitz B, Tseng SC, van Setten G, Wilson SE. Yiu SC; Dysfunctional Tear Syndrome Study Group. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea. 2006;25:900–7. Behrens A, Doyle JJ, Stern L, Chuck RS, McDonnell PJ, Azar DT, Dua HS, Hom M, Karpecki PM, Laibson PR, Lemp MA, Meisler DM, Del Castillo JM, O'Brien TP, Pflugfelder SC, Rolando M, Schein OD, Seitz B, Tseng SC, van Setten G, Wilson SE. Yiu SC; Dysfunctional Tear Syndrome Study Group. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea. 2006;25:900–7.
15.
go back to reference Lemp MA. Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes. CLAO J. 1995;21:221–32. Lemp MA. Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes. CLAO J. 1995;21:221–32.
16.
go back to reference Lam H, Bleiden L, De Paiva CS, Farley W, Stern ME, Pflugfelder SC. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009;147:198–205.CrossRefPubMed Lam H, Bleiden L, De Paiva CS, Farley W, Stern ME, Pflugfelder SC. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009;147:198–205.CrossRefPubMed
17.
go back to reference The definition and classification of dry eye disease. Report of the definition and classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:75–92. The definition and classification of dry eye disease. Report of the definition and classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:75–92.
19.
go back to reference Mathews PM, et al. Functional impairment of reading in patients with dry eye. Br J Ophthalmol. 2017;101(4):481–6.CrossRefPubMed Mathews PM, et al. Functional impairment of reading in patients with dry eye. Br J Ophthalmol. 2017;101(4):481–6.CrossRefPubMed
20.
go back to reference Ridder WH 3rd, et al. Evaluation of reading speed and contrast sensitivity in dry eye disease. Optom Vis Sci. 2013;90(1):37–44.CrossRefPubMed Ridder WH 3rd, et al. Evaluation of reading speed and contrast sensitivity in dry eye disease. Optom Vis Sci. 2013;90(1):37–44.CrossRefPubMed
21.
go back to reference Pflugfelder SC, Corrales RM, Moore QL, Volpe E, Gumus K, Zaheer M, De Paiva CS. Markers of squamous metaplasia in tear dysfunction correlate with conjunctival interferon-gamma expression. Invest Ophthalmol Vis Sci. 2014;55:2003. Pflugfelder SC, Corrales RM, Moore QL, Volpe E, Gumus K, Zaheer M, De Paiva CS. Markers of squamous metaplasia in tear dysfunction correlate with conjunctival interferon-gamma expression. Invest Ophthalmol Vis Sci. 2014;55:2003.
23.
go back to reference Jackson DC, et al. Tear interferon-gamma as a biomarker for evaporative dry eye disease. Invest Ophthalmol Vis Sci. 2016;57(11):4824–30.CrossRefPubMed Jackson DC, et al. Tear interferon-gamma as a biomarker for evaporative dry eye disease. Invest Ophthalmol Vis Sci. 2016;57(11):4824–30.CrossRefPubMed
24.
go back to reference Lee SY, et al. Analysis of tear cytokines and clinical correlations in Sjogren syndrome dry eye patients and non-Sjogren syndrome dry eye patients. Am J Ophthalmol. 2013;156(2):247–53.CrossRefPubMed Lee SY, et al. Analysis of tear cytokines and clinical correlations in Sjogren syndrome dry eye patients and non-Sjogren syndrome dry eye patients. Am J Ophthalmol. 2013;156(2):247–53.CrossRefPubMed
Metadata
Title
Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye
Authors
Peter J. McDonnell
Stephen C. Pflugfelder
Michael E. Stern
David R. Hardten
Taryn Conway
Linda Villanueva
David A. Hollander
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2017
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-017-0646-5

Other articles of this Issue 1/2017

BMC Ophthalmology 1/2017 Go to the issue